Royalty Pharma (RPRX) came out with quarterly earnings of $1.17 per share, beating the Zacks Consensus Estimate of $1.11 per share. This compares to earnings of $1.04 per share a year ago. These ...
Kimbell Royalty Partners reported its third-quarter 2025 earnings, surpassing analysts’ expectations with an earnings per share (EPS) of $0.19, compared to the forecasted $0.15, marking a 26.67% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback